Amira Sayed Hanafy

775 total citations
18 papers, 596 citations indexed

About

Amira Sayed Hanafy is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Amira Sayed Hanafy has authored 18 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Amira Sayed Hanafy's work include Advanced Drug Delivery Systems (4 papers), Medicinal Plants and Neuroprotection (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Amira Sayed Hanafy is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Medicinal Plants and Neuroprotection (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Amira Sayed Hanafy collaborates with scholars based in Egypt, Germany and Spain. Amira Sayed Hanafy's co-authors include Ragwa M. Farid, Safaa S. El-Gamal, María J. Blanco‐Prieto, Samar O. El-Ganainy, Alf Lamprecht, Maged W. Helmy, Noha S. El-Salamouni, Ming Ming Wen, Wessam M. El-Refaie and Giovanni Tosi and has published in prestigious journals such as Nature Communications, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Amira Sayed Hanafy

17 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amira Sayed Hanafy Egypt 10 210 164 137 124 80 18 596
Nallupillai Paramakrishnan India 9 222 1.1× 140 0.9× 126 0.9× 231 1.9× 70 0.9× 19 596
K.P. Sampath Kumar India 5 227 1.1× 134 0.8× 122 0.9× 220 1.8× 84 1.1× 8 552
Rúben G. R. Pinheiro Portugal 5 87 0.4× 150 0.9× 98 0.7× 128 1.0× 47 0.6× 7 445
Thi Thuy Dung Nguyen Vietnam 11 82 0.4× 206 1.3× 240 1.8× 74 0.6× 90 1.1× 27 703
Ming Ming Wen Egypt 11 176 0.8× 164 1.0× 73 0.5× 128 1.0× 41 0.5× 18 536
Anila Mathew Japan 10 105 0.5× 151 0.9× 149 1.1× 258 2.1× 80 1.0× 16 711
Wan Xu China 11 159 0.8× 345 2.1× 198 1.4× 309 2.5× 81 1.0× 13 784
Enara Herrán Spain 13 206 1.0× 324 2.0× 98 0.7× 156 1.3× 39 0.5× 18 765
Chengcheng Feng China 12 196 0.9× 228 1.4× 59 0.4× 175 1.4× 32 0.4× 22 601
Kang Qian China 14 106 0.5× 326 2.0× 227 1.7× 189 1.5× 65 0.8× 31 835

Countries citing papers authored by Amira Sayed Hanafy

Since Specialization
Citations

This map shows the geographic impact of Amira Sayed Hanafy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amira Sayed Hanafy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amira Sayed Hanafy more than expected).

Fields of papers citing papers by Amira Sayed Hanafy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amira Sayed Hanafy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amira Sayed Hanafy. The network helps show where Amira Sayed Hanafy may publish in the future.

Co-authorship network of co-authors of Amira Sayed Hanafy

This figure shows the co-authorship network connecting the top 25 collaborators of Amira Sayed Hanafy. A scholar is included among the top collaborators of Amira Sayed Hanafy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amira Sayed Hanafy. Amira Sayed Hanafy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hanafy, Amira Sayed. (2024). Revisiting cerebral endothelial cells in Alzheimer’s disease. Neural Regeneration Research. 20(10). 2911–2912.
2.
Hanafy, Amira Sayed, Alf Lamprecht, & Dirk Dietrich. (2023). Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer’s model. Fluids and Barriers of the CNS. 20(1). 85–85. 5 indexed citations
3.
Hanafy, Amira Sayed, Julika Pitsch, Albert J. Becker, et al.. (2023). Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slices. Nature Communications. 14(1). 481–481. 9 indexed citations
4.
El-Ganainy, Samar O., Tony Cijsouw, Mennatallah A. Ali, Susanne Schoch, & Amira Sayed Hanafy. (2022). Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers. Expert Review of Neurotherapeutics. 22(4). 319–335. 3 indexed citations
5.
6.
El-Salamouni, Noha S. & Amira Sayed Hanafy. (2021). Hyaluronic-benzydamine oromucosal films outperform conventional mouth rinse in ulcer healing. Journal of Drug Delivery Science and Technology. 65. 102690–102690. 7 indexed citations
7.
Hanafy, Amira Sayed, Dirk Dietrich, Gert Fricker, & Alf Lamprecht. (2021). Blood-brain barrier models: Rationale for selection. Advanced Drug Delivery Reviews. 176. 113859–113859. 39 indexed citations
8.
Farid, Ragwa M., et al.. (2021). Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect. Drug Development and Industrial Pharmacy. 47(5). 735–740. 15 indexed citations
9.
El-Ganainy, Samar O., et al.. (2021). Galantamine Nanoparticles Outperform Oral Galantamine in An Alzheimer’S Rat Model: Pharmacokinetics and Pharmacodynamics. Nanomedicine. 16(15). 1281–1296. 19 indexed citations
10.
Hanafy, Amira Sayed, et al.. (2020). Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model. Drug Development and Industrial Pharmacy. 46(6). 996–1004. 7 indexed citations
11.
Hanafy, Amira Sayed, Susanne Schoch, & Alf Lamprecht. (2020). CRISPR/Cas9 Delivery Potentials in Alzheimer’s Disease Management: A Mini Review. Pharmaceutics. 12(9). 801–801. 27 indexed citations
12.
Hanafy, Amira Sayed & Samar O. El-Ganainy. (2019). Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in rats. International Journal of Pharmaceutics. 573. 118859–118859. 42 indexed citations
13.
Saludas, Laura, et al.. (2018). Micro- and nanotechnology approaches to improve Parkinson's disease therapy. Journal of Controlled Release. 295. 201–213. 58 indexed citations
14.
Hanafy, Amira Sayed, Ragwa M. Farid, Maged W. Helmy, & Safaa S. El-Gamal. (2016). Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management. Drug Delivery. 23(8). 3111–3122. 80 indexed citations
15.
Wen, Ming Ming, Noha S. El-Salamouni, Wessam M. El-Refaie, et al.. (2016). Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release. 245. 95–107. 156 indexed citations
16.
Sokar, Magda, Amira Sayed Hanafy, Amal H. El‐Kamel, & Safaa S. El-Gamal. (2015). Design of chronomodulated drug delivery system of valsartan: in vitro characterization. Indian Journal of Pharmaceutical Sciences. 77(4). 470–470. 9 indexed citations
17.
Hanafy, Amira Sayed, Ragwa M. Farid, & Safaa S. El-Gamal. (2015). Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain. Drug Development and Industrial Pharmacy. 41(12). 2055–2068. 100 indexed citations
18.
El-Habashy, Salma E., Chris E. Adkins, Ming Ming Wen, et al.. (2014). Novel Treatment Strategies for Brain Tumors and Metastases. Pharmaceutical Patent Analyst. 3(3). 279–296. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nallupillai Paramakrishnan Breakdown of academic impact, for papers by K.P. Sampath Kumar Breakdown of academic impact, for papers by Rúben G. R. Pinheiro Breakdown of academic impact, for papers by Thi Thuy Dung Nguyen Breakdown of academic impact, for papers by Ming Ming Wen Breakdown of academic impact, for papers by Anila Mathew Breakdown of academic impact, for papers by Wan Xu Breakdown of academic impact, for papers by Enara Herrán Breakdown of academic impact, for papers by Chengcheng Feng Breakdown of academic impact, for papers by Kang Qian
Rankless by CCL
2026